Management options for primary hepatocellular carcinoma: An overview

Acta Oncologica

Volumn 33, Issue 8, 1994, Pages 895-900

  Paraskevopoulos, John A ^a  

^a ATHENS MEDICAL CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA INTERFERON; AMSACRINE; ANTINEOPLASTIC AGENT; DOXORUBICIN; FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 2; IODINATED POPPYSEED OIL; SEMUSTINE; SEX HORMONE; STREPTOZOCIN; THORIUM DIOXIDE; ZINOSTATIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS;

EID: 0028584123     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869409098452     Document Type: Article

References (64)

1. Epidemiology of hepatocellular carcinoma
2. Clinical pattern and natural history of hepatocellular carcinoma
3. Hepatocellular carcinoma and hepatitis B virus
4. Risk factors for hepatocellular carcinoma among patients with chronic liver disease
5. Hepatitis B virus and primary liver cancer: a molecular approach
6. National history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
7. Intratumour injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma
8. Three-year survival rate of small HCC treated by percutaneous ethanol injection: a study of 86 patients
9. A seventeen-year experience of cryosurgery for primary liver cancer
10. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases
11. Freezing injury to large blood vessels in dogs with comments on the effect of experimental freezing of bile ducts
12. Hepatocellular carcinoma in cirrhosis: the European experience
13. Results of surgical treatment; follow up study by Liver Cancer Study Group of Japan
14. Experience with resection of primary hepatic malignancy
15. Results of resection of HCC in cirrhotic patients. An analysis of the European experience
16. Clinical experience with 118 hepatic resections for hepatocellular carcinoma
17. Personal experience with 411 hepatic resections
18. Hepatic resection for hepatocellular carcinoma
19. Hepatic resection versus transplantation for hepatocellular carcinoma
20. Surgical management of large hepatocellular carcinomas: criteria for curative hepa-tectomy
21. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis
22. Status of ischaemic therapy for hepatic tumours
23. Postoperative recurrence of hepatocellular carcinoma
24. Risk factors linked to tumour recurrence of human hepatocellular carcinoma after hepatic resection
25. Risk factors for tumour recurrence and prognosis after curative resection of hepatocellular carcinoma
26. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumour stage and recurrence
27. Liver transplantation for malignant disease. Results in 93 consecutive patients
28. Liver transplantation for hepatocellular carcinoma: clinical results and future aspects
29. Liver transplantation in the treatment of primary liver cancer
30. Is liver transplantation justified for the treatment of hepatic malignancies?
31. Liver transplantation for hepatocellular carcinoma
32. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver
33. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
34. Medical treatment of hepatocellular carcinoma
35. Doxorubicin versus no antitumour therapy in inoperable hepatocellular carcinoma
36. Adriamycin treatment for hepatocellular carcinoma
37. Prognostic factors for survival in hepatocellular carcinoma
38. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy: identification of two groups of patients with prospects for prolonged survival
39. Hepatomas: Hormone receptors and therapy
40. Failure of ketoconazole as anti-androgen therapy in nonresectable primary hepatocellular carcinoma
41. Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver
42. Biodegradable mitomycin C microspheres given intraarterially for inoperable hepatic cancer
43. Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma
44. 131I anti-AFP
45. Hepatic artery injection of I 131 labelled lipiodol
46. Recombinant human gamma interferon in primary hepatocellular carcinoma
47. Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study
48. Recombinant leucocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasm and implication for hepatocellular carcinoma
49. Observations on the systemic administration of autologous lymphokine-acti-vated killer cell and recombinant interleukin-2 to patients with metastatic cancer
50. Lysis of primary hepatic tumours of lymphokine-activated killer cells
51. Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer
52. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment
53. Experience with liver resection after hepatic arterial chemoembolisation for hepatocellular carcinoma
54. Epidemiology of hepatocellular carcinoma
55. Approach to primary liver cancer
56. Hepatic resection in patients with cirrhosis and hepatocellular carcinoma
57. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis
58. The prognostic significance of macroscopic growth pattern of hepatocellular carcinoma
59. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy
60. Changing trends in hepatic resection for malignant liver tumours
61. Hepatocellular carcinoma
62. Treatment of hepatocellular carcinoma with transcatheter arterial embolisation. Analysis of prognostic factors
63. Cryosurgery in the treatment of cancer
64. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein